These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 22719179)

  • 41. KLF2 regulates neutrophil migration by modulating CXCR1 and CXCR2 in asthma.
    Zhu LM; Zeng D; Lei XC; Huang J; Deng YF; Ji YB; Liu J; Dai FF; Li YZ; Shi DD; Zhu YQ; Dai AG; Wang Z
    Biochim Biophys Acta Mol Basis Dis; 2020 Dec; 1866(12):165920. PubMed ID: 32800946
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Fluoroalkyl alpha side chain containing 3,4-diamino-cyclobutenediones as potent and orally bioavailable CXCR2-CXCR1 dual antagonists.
    Biju P; Taveras AG; Dwyer MP; Yu Y; Chao J; Hipkin RW; Fan X; Rindgen D; Fine J; Lundell D
    Bioorg Med Chem Lett; 2009 Mar; 19(5):1431-3. PubMed ID: 19196511
    [TBL] [Abstract][Full Text] [Related]  

  • 43. ELR-CXC chemokine receptor antagonism targets inflammatory responses at multiple levels.
    Zhao X; Town JR; Li F; Zhang X; Cockcroft DW; Gordon JR
    J Immunol; 2009 Mar; 182(5):3213-22. PubMed ID: 19234219
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The chemokine receptors CXCR1/CXCR2 modulate antigen-induced arthritis by regulating adhesion of neutrophils to the synovial microvasculature.
    Coelho FM; Pinho V; Amaral FA; Sachs D; Costa VV; Rodrigues DH; Vieira AT; Silva TA; Souza DG; Bertini R; Teixeira AL; Teixeira MM
    Arthritis Rheum; 2008 Aug; 58(8):2329-37. PubMed ID: 18668539
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Fine-Tuning of GPCR-Chemokine Interactions. Design and Identification of Chemokine Analogues as Receptor Agonists, Biased Agonists, and Antagonists.
    Navarro J
    Biochemistry; 2019 Mar; 58(10):1432-1439. PubMed ID: 30726064
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Intracellular trafficking of human CXCR1 and CXCR2: regulation by receptor domains and actin-related kinases.
    Matityahu E; Feniger-Barish R; Meshel T; Zaslaver A; Ben-Baruch A
    Eur J Immunol; 2002 Dec; 32(12):3525-35. PubMed ID: 12442335
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Discovery of 2-hydroxy-N,N-dimethyl-3-{2-[[(R)-1-(5- methylfuran-2-yl)propyl]amino]-3,4-dioxocyclobut-1-enylamino}benzamide (SCH 527123): a potent, orally bioavailable CXCR2/CXCR1 receptor antagonist.
    Dwyer MP; Yu Y; Chao J; Aki C; Chao J; Biju P; Girijavallabhan V; Rindgen D; Bond R; Mayer-Ezel R; Jakway J; Hipkin RW; Fossetta J; Gonsiorek W; Bian H; Fan X; Terminelli C; Fine J; Lundell D; Merritt JR; Rokosz LL; Kaiser B; Li G; Wang W; Stauffer T; Ozgur L; Baldwin J; Taveras AG
    J Med Chem; 2006 Dec; 49(26):7603-6. PubMed ID: 17181143
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A crucial role for TNF-alpha in mediating neutrophil influx induced by endogenously generated or exogenous chemokines, KC/CXCL1 and LIX/CXCL5.
    Vieira SM; Lemos HP; Grespan R; Napimoga MH; Dal-Secco D; Freitas A; Cunha TM; Verri WA; Souza-Junior DA; Jamur MC; Fernandes KS; Oliver C; Silva JS; Teixeira MM; Cunha FQ
    Br J Pharmacol; 2009 Oct; 158(3):779-89. PubMed ID: 19702783
    [TBL] [Abstract][Full Text] [Related]  

  • 49. CXCR2--the receptor to hit?
    Reutershan J
    Drug News Perspect; 2006 Dec; 19(10):615-23. PubMed ID: 17299604
    [TBL] [Abstract][Full Text] [Related]  

  • 50. New CXCR1/CXCR2 inhibitors represent an effective treatment for kidney or head and neck cancers sensitive or refractory to reference treatments.
    Dufies M; Grytsai O; Ronco C; Camara O; Ambrosetti D; Hagege A; Parola J; Mateo L; Ayrault M; Giuliano S; Grépin R; Lagarde N; Montes M; Auberger P; Demange L; Benhida R; Pagès G
    Theranostics; 2019; 9(18):5332-5346. PubMed ID: 31410218
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cloning and characterization of guinea pig CXCR1.
    Takahashi M; Jeevan A; Sawant K; McMurray DN; Yoshimura T
    Mol Immunol; 2007 Feb; 44(5):878-88. PubMed ID: 16712933
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Expression of CXC chemokine receptors 1 and 2 in human bronchial epithelial cells.
    Farkas L; Hahn MC; Schmoczer M; Jentsch N; Krätzel K; Pfeifer M; Schulz C
    Chest; 2005 Nov; 128(5):3724-34. PubMed ID: 16304340
    [TBL] [Abstract][Full Text] [Related]  

  • 53. CXCR1/CXCR2 antagonism is effective in pulmonary defense against Klebsiella pneumoniae infection.
    Wei J; Peng J; Wang B; Qu H; Wang S; Faisal A; Cheng JW; Gordon JR; Li F
    Biomed Res Int; 2013; 2013():720975. PubMed ID: 23586055
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Blockade of the chemokine receptor CXCR2 ameliorates adjuvant-induced arthritis in rats.
    Barsante MM; Cunha TM; Allegretti M; Cattani F; Policani F; Bizzarri C; Tafuri WL; Poole S; Cunha FQ; Bertini R; Teixeira MM
    Br J Pharmacol; 2008 Mar; 153(5):992-1002. PubMed ID: 17891165
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pharmacological characterization of AZD5069, a slowly reversible CXC chemokine receptor 2 antagonist.
    Nicholls DJ; Wiley K; Dainty I; MacIntosh F; Phillips C; Gaw A; Mårdh CK
    J Pharmacol Exp Ther; 2015 May; 353(2):340-50. PubMed ID: 25736418
    [TBL] [Abstract][Full Text] [Related]  

  • 56. CXC chemokine receptor-2 ligands are necessary components of neutrophil-mediated host defense in invasive pulmonary aspergillosis.
    Mehrad B; Strieter RM; Moore TA; Tsai WC; Lira SA; Standiford TJ
    J Immunol; 1999 Dec; 163(11):6086-94. PubMed ID: 10570298
    [TBL] [Abstract][Full Text] [Related]  

  • 57. CXCR2/CXCR2 ligand biology during lung transplant ischemia-reperfusion injury.
    Belperio JA; Keane MP; Burdick MD; Gomperts BN; Xue YY; Hong K; Mestas J; Zisman D; Ardehali A; Saggar R; Lynch JP; Ross DJ; Strieter RM
    J Immunol; 2005 Nov; 175(10):6931-9. PubMed ID: 16272353
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Role of CXC chemokine receptor-2 in a murine model of bronchopulmonary dysplasia.
    Hogmalm A; Bäckström E; Bry M; Lappalainen U; Lukkarinen HP; Bry K
    Am J Respir Cell Mol Biol; 2012 Dec; 47(6):746-58. PubMed ID: 22865624
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Interleukin-8 Receptors CXCR1 and CXCR2 Are Not Expressed by Endothelial Colony-forming Cells.
    Blandinières A; Hong X; Philippe A; Bièche I; Vacher S; Rossi E; Detriche G; Gendron N; Gaussem P; Guerin CL; Melero-Martin JM; Smadja DM
    Stem Cell Rev Rep; 2021 Apr; 17(2):628-638. PubMed ID: 33185837
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Differential activation and regulation of CXCR1 and CXCR2 by CXCL8 monomer and dimer.
    Nasser MW; Raghuwanshi SK; Grant DJ; Jala VR; Rajarathnam K; Richardson RM
    J Immunol; 2009 Sep; 183(5):3425-32. PubMed ID: 19667085
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.